Clinical Trials Browser

Completed × pazopanib × Thoracic × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00775307 2019-09-24

Adjuvant Pazopanib in Stage I NSCLC

Phase 2/3 Completed

142 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01253369 2019-04-23

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

33 enrolled 8 charts

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00619424 2017-11-17

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Phase 1 Completed

58 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00866528 2017-11-13

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

Phase 1 Completed

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01262820 2017-03-07

LCCC0921

Phase 2 Completed

15 enrolled 10 charts

Thoracic

Lung Neoplasms

NCT01027598 2016-01-29

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

202 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00871403 2013-06-20

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

Phase 2 Completed

107 enrolled 12 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00367679 2012-06-12

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Phase 2 Completed

35 enrolled 13 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

IVY

Adjuvant Pazopanib in Stage I NSCLC

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

LCCC0921

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer